FDA Approves Ibalizumab-Uiyk For Administration By IV Push For Maintenance Dosing For Treatment Of HIV-1 Infection

Infectious Disease Advisor (10/5, Park) reports the FDA “has approved Trogarzo® (ibalizumab-uiyk) for administration by intravenous (IV) push for maintenance dosing.” The drug “is a CD4-directed post-attachment human immunodeficiency virus type 1 (HIV-1)...